Parvoviridae

Fields Virology: Sixth Edition

Volumn 1, Issue , 2013, Pages

  Berns, Kenneth I ^a   Parrish, Colin R ^b  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b Cornell University ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84901248049     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (484)

1. Aasted B, Alexandersen S, Christensen J. Vaccination with Aleutian mink disease parvovirus (AMDV) capsid proteins enhances disease, while vaccination with the major non-structural AMDV protein causes partial protection from disease. Vaccine 1998; 16: 1158-1165.
2. Acland GM, Aguirre GD, Ray J, et al. Gene therapy restores vision in a canine model of childhood blindness. Nat Genet 2001; 28: 92-95.
3. Adeyemi RO, Landry S, Davis ME, et al. Parvovirus minute virus of mice induces a DNA damage response that facilitates viral replication. PLoS Pathog 2010; 6(10): e1001141.
4. Agbandje M, McKenna R, Rossmann MG, et al. Structure determination of feline panleukopenia virus empty particles. Proteins 1993; 16: 155-171.
5. Agbandje-McKenna M, Kleinschmidt J. AAV capsid structure and cell interactions. Methods Mol Biol 2011; 807: 47-92.
6. Agbandje-McKenna M, Llamas-Saiz AL, Wang F, et al. Functional implications of the structure of the murine parvovirus, minute virus of mice. Structure 1998; 6: 1369-1381.
7. Ahn JK, Pitluk ZW, Ward DC. The GC box and TATA transcription control elements in the P38 promoter of the minute virus of mice are necessary and sufficient for transactivation by the nonstructural protein NS1. J Virol 1992; 66: 3776-3783.
8. Alazard-Dany N, Nicolas A, Ploquin A, et al. Definition of herpes simplex virus type 1 helper activities for adeno-associated virus early replication events. PLoS Pathog 2009; 5: e1000340.
9. Alexandersen S. Acute interstitial pneumonia in mink kits: experimental reproduction of the disease. Vet Pathol 1986; 23: 579-588.
10. Alexandersen S, Bloom ME, Wolfinbarger J. Evidence of restricted viral replication in adult mink infected with Aleutian disease of mink parvovirus. J Virol 1988; 62: 1495-1507.
11. Alexandersen S, Larsen S, Aasted B, et al. Acute interstitial pneumonia in mink kits inoculated with defined isolates of Aleutian mink disease parvovirus. Vet Pathol 1994; 31: 216-228.
12. Alexandersen S, Storgaard T, Kamstrup N, et al. Pathogenesis of Aleutian mink disease parvovirus infection: effects of suppression of antibody response on viral mRNA levels and on development of acute disease. J Virol 1994; 68: 738-749.
13. Allan GM, Kennedy S, McNeilly F, et al. Experimental reproduction of severe wasting disease by co-infection of pigs with porcine circovirus and porcine parvovirus. J Comp Pathol 1999; 121: 1-11.
14. Allander T, Emerson SU, Engle RE, et al. A virus discovery method incorporating DNase treatment and its application to the identification of two bovine parvovirus species. Proc Natl Acad Sci U S A 2001; 98: 11609-11614.
15. Allander T, Tammi MT, Eriksson M, et al. Cloning of a human parvovirus by molecular screening of respiratory tract samples. Proc Natl Acad Sci U S A 2005; 102: 12891-12896.
16. Allison AB, Harbison CE, Pagan I, et al. Role of multiple hosts in the cross-species transmission and emergence of a pandemic parvovirus. J Virol 2012; 86: 865-872.
17. Anand A, Gray ES, Brown T, et al. Human parvovirus infection in pregnancy and hydrops fetalis. N Engl J Med 1987; 316: 183-186.
18. Anderson LJ, Hurwitz ES. Human parvovirus B19 and pregnancy. Clin Perinatol 1988; 15: 273-286.
19. Anderson MJ, Higgins PG, Davis LR, et al. Experimental parvoviral infection in humans. J Infect Dis 1985; 152: 257-265.
20. Anderson MJ, Jones SE, Minson AC. Diagnosis of human parvovirus infection by dot-blot hybridization using cloned viral DNA. J Med Virol 1985; 15: 163-172.
21. Anderson MJ, Lewin E, Kidd IM, et al. An outbreak of erythrema infectiosum associated with human parvovirus infection. J Hyg 1984; 93: 85.
22. Astell C, Thomson M, Merchlinsky M, et al. The complete sequence of minute virus of mice, an autonomous parvovirus. Nucleic Acids Res 1981; 11: 999-1018.
23. Astell CR, Chow MB, Ward DC. Sequence analysis of the termini of virion and replicative forms of minute virus of mice DNA suggest a modified rolling hairpin model for autonomous parvovirus DNA replication. J Virol 1985; 54: 171-177.
24. Atchison RW, Casto BC, Hammon WM. Adenovirus-associated defective virus particles. Science 1965; 149: 754-756.
25. Badgett MR, Auer A, Carmichael LE, et al. Evolutionary dynamics of viral attenuation. J Virol 2002; 76: 10524-10529.
26. Baldauf AQ, Willwand K, Mumtsidu E, et al. Specific initiation of replication at the right-end telomere of the closed species of minute virus of mice replicative-form DNA. J Virol 1997; 71: 971-980.
27. Ball-Goodrich LJ, Johnson E. Molecular characterization of a newly recognized mouse parvovirus. J Virol 1994; 68: 6476-6486.
28. Ball-Goodrich LJ, Leland SE, Johnson EA, et al. Rat parvovirus type 1: the prototype for a new rodent parvovirus serogroup. J Virol 1998; 72: 3289-3299.
29. Ball-Goodrich LJ, Tattersall P. Two amino acid substitutions within the capsid are coordinately required for acquisition of fibrotropism by the lymphotropic strain of minute virus of mice. J Virol 1992; 66: 3415-3423.
30. Ballou WR, Reed JL, Noble W, et al. Safety and immunogenicity of a recombinant parvovirus B19 vaccine formulated with MF59C.1. J Infect Dis 2003; 187: 675-678.
31. Bansal GP, Hatfield JA, Dunn FE, et al. Candidate recombinant vaccine for human B19 parvovirus. J Infect Dis 1993; 167: 1034-1044.
32. Bantel-Schaal U, zur Hausen H. Characterization of the DNA of a defective human parvovirus isolated from a genital site. Virology 1984; 134: 52-63.
33. Bar S, Daeffler L, Rommelaere J, et al. Vesicular egress of non-enveloped lytic parvoviruses depends on gelsolin functioning. PLoS Pathog 2008; 4: e1000126.
34. Barbis DP, Chang S-F, Parrish CR. Mutations adjacent to the dimple of canine parvovirus capsid structure affect sialic acid binding. Virology 1992; 191: 301-308.
35. Bartlett JS, Wilcher R, Samulski RJ. Infectious entry pathway of adeno-associated virus and adeno-associated virus vectors. J Virol 2000; 74: 2777-2785.
36. Basak S, Turner H. Infectious entry pathway for canine parvovirus. Virology 1992; 186: 368-376.
37. Basak S, Turner H, Parr S. Identification of a 40- to 42-kDa attachment polypeptide for canine parvovirus in A72 cells. Virology 1994; 205: 7-16.
38. Bashir T, Rommelaere J, Cziepluch C. In vivo accumulation of cyclin A and cellular replication factors in autonomous parvovirus minute virus of mice-associated replication bodies. J Virol 2001; 75: 4394-4398.
39. Bell LM, Naides SJ, Stoffman P, et al. Human parvovirus B19 infection among hospital staff members after contact with infected patients. N Engl J Med 1989; 321: 485-491.
40. Belloy M, Morinet F, Blondin G, et al. Erythroid hypoplasia due to chronic infection with parvovirus B19. N Engl J Med 1990; 322: 633-634.
41. Belyi VA, Levine AJ, Skalka AM. Sequences from ancestral single-stranded DNA viruses in vertebrate genomes: the Parvoviridae and Circoviridae are more than 40 to 50 million years old. J Virol 2010; 84: 12458-12462.
42. Bergeron J, Hebert B, Tijssen P. Genome organization of the Kresse strain of porcine parvovirus: identification of the allotropic determinant and comparison with those of NADL-2 and field isolates. J Virol 1996; 70: 2508-2515.
43. Bernstein DI, El Sahly HM, Keitel WA, et al. Safety and immunogenicity of a candidate parvovirus B19 vaccine. Vaccine 2011; 29: 7357-7363.
44. Besselsen DG, Franklin CL, Livingston RS, et al. Lurking in the shadows: emerging rodent infectious diseases. ILAR J 2008; 49: 277-290.
45. Besselsen DG, Romero MJ, Wagner AM, et al. Identification of novel murine parvovirus strains by epidemiological analysis of naturally infected mice. J Gen Virol 2006; 87: 1543-1556.
46. Binn LN, Lazar EC, Eddy GA, et al. Recovery and characterization of a minute virus of canines. Infect Immun 1970; 1: 503-508.
47. Blacklow NR, Hoggan MD, Kapikian AZ, et al. Epidemiology of adenovirus-associated virus infection in a nursery population. Am J Epidemiol 1968; 88: 368-378.
48. Blacklow NR, Hoggan MD, Rowe WP. Isolation of adenovirus-associated viruses from man. Proc Natl Acad Sci U S A 1967; 58: 1410-1415.
49. Blacklow NR, Hoggan MD, Sereno MS, et al. A seroepidemiologic study of adenovirus-associated virus infection in infants and children. Am J Epidemiol 1971; 94: 359-366.
50. Bloom ME, Fox JM, Berry BD, et al. Construction of pathogenic molecular clones of Aleutian mink disease parvovirus that replicate both in vivo and in vitro. Virology 1998; 251: 288-296.
51. Bloom ME, Kaaden O-R, Huggans E, et al. Molecular comparisons of in vivo and in vitro derived strains of Aleutian disease of mink parvovirus. J Virol 1988; 62: 132-138.
52. Bloom ME, Kanno H, Mori S, et al. Aleutian mink disease: puzzles and paradigms. Infect Agents Dis 1994; 3: 1-23.
53. Blundell MC, Beard C, Astell CR. In vitro identification of a B19 parvovirus promoter. Virology 1987; 157: 534-538.
54. Brister JR, Muzyczka N. Mechanism of Rep-mediated adeno-associated virus origin nicking. J Virol 2000; 74: 7762-7771.
55. Brister JR, Muzyczka N. Rep-mediated nicking of the adeno-associated virus origin requires two biochemical activities, DNA helicase activity and transesterification. J Virol 1999; 73: 9325-9336.
56. Broll S, Alexandersen S. Investigation of the pathogenesis of transplacental transmission of Aleutian mink disease parvovirus in experimentally infected mink. J Virol 1996; 70: 1455-1466.
57. Brown KE, Anderson SM, Young NS. Erythrocyte P antigen: cellular receptor for B19 parvovirus. Science 1993; 262: 114-117.
58. Brown KE, Green SW, Young NS. Goose parvovirus-an autonomous member of the dependovirus genus? Virology 1995; 210: 283-291.
59. Brown KE, Hibbs JR, Gallinella G, et al. Resistance to parvovirus B19 infection due to lack of virus receptor (erythrocyte P antigen). N Engl J Med 1994; 330: 1192-1196.
60. Brown KE, Young NS. Human parvovirus B19 infections in infants and children. Adv Pediatr Infect Dis 1997; 13: 101-126.
61. Brown KE, Young NS. Parvovirus B19 infection and hematopoiesis. Blood Rev 1995; 9: 176-182.
62. Brown KE, Young NS. The simian parvoviruses. Rev Med Virol 1997; 7(4): 211-218.
63. Brown KE, Young NS, Liu JM. Molecular, cellular and clinical aspects of parvovirus B19 infection. Crit Rev Oncol Hematol 1994; 16: 1-31.
64. Brown TT Jr, Paul PS, Mengeling WL. Response of conventionally raised weanling pigs to experimental infection with a virulent strain of porcine parvovirus. Am J Vet Res 1980; 41: 1221-1224.
65. Brownstein DG, Smith AL, Jacoby RO, et al. Pathogenesis of infection with a virulent allotropic variant of minute virus of mice and regulation by host genotype. Lab Invest 1991; 65: 357-364.
66. Brownstein DG, Smith AL, Johnson EA, et al. The pathogenesis of infection with minute virus of mice depends on expression of the small nonstructural protein NS2 and on the genotype of the allotropic determinants VP1 and VP2. J Virol 1992; 66: 3118-3124.
67. Brunstein J, Astell CR. Analysis of the internal replication sequence indicates that there are three elements required for efficient replication of minute virus of mice minigenomes. J Virol 1997; 71: 9087-9095.
68. Buller R, Janik J, Sebring E, et al. Herpes simplex virus type 1 and 2 completely help adeno-associated virus replication. J Virol 1981; 40: 241-247.
69. Buonavoglia C, Martella V, Pratelli A, et al. Evidence for evolution of canine parvovirus type 2 in Italy. J Gen Virol 2001; 82: 3021-3025.
70. Burguete T, Rabreau M, Fontanges-Darriet M, et al. Evidence for infection of the human embryo with adeno-associated virus in pregnancy. Hum Reprod 1999; 14: 2396-2401.
71. Canaan S, Zadori Z, Ghomashchi F, et al. Interfacial enzymology of parvovirus phospholipases A2. J Biol Chem 2004 279:14502-14508.
72. Candotti D, Etiz N, Parsyan A, et al. Identification and characterization of persistent human erythrovirus infection in blood donor samples. J Virol 2004; 78: 12169-12178.
73. Carlson JH, Scott FW. Feline panleukopenia. II. The relationship of intestinal mucosal cell proliferation to viral infection and development of lesions. Vet Pathol 1977; 14: 173-181.
74. Carman PS, Povey RC. Pathogenesis of canine parvovirus-2 in dogs: hematology, serology and virus recovery. Res Vet Sci 1985; 38: 134-140.
75. Carman PS, Povey RC. Pathogenesis of canine parvovirus-2 in dogs-histopathology and antigen identification in tissues. Res Vet Sci 1985; 38: 141-150.
76. Carmichael LE, Joubert JC, Pollock RV. A modified live canine parvovirus strain with novel plaque characteristics. I. Viral attenuation and dog response. Cornell Vet 1981; 71: 408-427.
77. Carmichael LE, Joubert JC, Pollock RVH. A modified canine parvovirus vaccine 2. Immune response. Cornell Vet 1983; 73: 13-29.
78. Carmichael LE, Schlafer DH, Hashimoto A. Minute virus of canines (MVC, canine parvovirus type-1): pathogenicity for pups and seroprevalence estimate. J Vet Diagn Invest 1994; 6: 165-174.
79. Carter BJ. Adeno-associated virus vectors in clinical trials. Hum Gene Ther 2005; 16: 541-550.
80. Carter BJ, Antoni BA, Klessig DF. Adenovirus containing a deletion of the early region 2A gene allows growth of adeno-associated virus with decreased efficiency. Virology 1992; 191: 473-476.
81. Casto BC, Atchison RW, Hammon WM. Studies on the relationship between adeno-associated virus type 1 (AAV-1) and adenoviruses. I. Replication of AAV-1 in certain cell cultures and its effect on helper adenovirus. Virology 1967; 32: 52-59.
82. Casto BC, Goodheart CR. Inhibition of adenovirus transformation in vitro by AAV-1. Proc Soc Exp Biol Med 1972; 140: 72-78.
83. Caul EO, Usher MJ, Burton PA. Intrauterine infection with human parvovirus B19: a light and electron microscopy study. J Med Virol 1988; 24: 55-66.
84. Cearley CN, Wolfe JH. Transduction characteristics of adeno-associated virus vectors expressing cap serotypes 7, 8, 9, and Rh10 in the mouse brain. Mol Ther 2006; 13: 528-537.
85. Chang SF, Sgro JY, Parrish CR. Multiple amino acids in the capsid structure of canine parvovirus coordinately determine the canine host range and specific antigenic and hemagglutination properties. J Virol 1992; 66: 6858-6567.
86. Chao H, Liu Y, Rabinowitz J, et al. Several log increase in therapeutic transgene delivery by distinct adeno-associated viral serotype vectors. Mol Ther 2000; 2: 619-623.
87. Chapman MS, Rossmann MG. Structure, sequence, and function correlations among parvoviruses. Virology 1993; 194: 491-508.
88. Chejanovsky N, Carter BJ. Mutagenesis of an AUG codon in the adeno-associated virus rep gene: effects on viral DNA replication. Virology 1989; 173: 120-128.
89. Chen AY, Cheng F, Lou S, et al. Characterization of the gene expression profile of human bocavirus. Virology 2010; 403: 145-154.
90. Chen Z, Chen AY, Cheng F, et al. Chipmunk parvovirus is distinct from members in the genus Erythrovirus of the family Parvoviridae. PLoS One 2010; 5: e15113.
91. Cheung AK, Hoggan MD, Hauswirth WW, et al. Integration of the adeno-associated virus genome into cellular DNA in latently infected human Detroit 6 cells. J Virol 1980; 33: 739-748.
92. Chiorini JA, Wiener SM, Owens RA, et al. Sequence requirements for stable binding and function of Rep68 on the adeno-associated virus type 2 inverted terminal repeats. J Virol 1994; 68: 7448-7457.
93. Chiorini JA, Yang L, Safer B, et al. Determination of adeno-associated virus Rep68 and Rep78 binding sites by random sequence oligonucleotide selection. J Virol 1995; 69: 7334-7338.
94. Choi EY, Newman AE, Burger L, et al. Replication of minute virus of mice DNA is critically dependent on accumulated levels of NS2. J Virol 2005; 79: 12375-12381.
95. Choi VW, McCarty DM, Samulski RJ. AAV hybrid serotypes: improved vectors for gene delivery. Curr Gene Ther 2005; 5: 299-310.
96. Chorba T, Coccia P, Holman RC, et al. The role of parvovirus B19 in aplastic crisis and erythema infectiosum (fifth disease). J Infect Dis 1986; 154: 383-393.
97. Christensen J, Cotmore SF, Tattersall P. A novel cellular site-specific DNA-binding protein cooperates with the viral NS1 polypeptide to initiate parvovirus DNA replication. J Virol 1997; 71: 1405-1416.
98. Christensen J, Cotmore SF, Tattersall P. Minute virus of mice transcriptional activator protein NS1 binds directly to the transactivation region of the viral P38 promoter in a strictly ATP-dependent manner. J Virol 1995; 69: 5422-5430.
99. Christensen J, Cotmore SF, Tattersall P. Parvovirus initiation factor PIF: a novel human DNA-binding factor which coordinately recognizes two ACGT motifs. J Virol 1997; 71: 5733-5741.
100. Christensen J, Cotmore SF, Tattersall P. Two new members of the emerging KDWK family of combinatorial transcription modulators bind as a heterodimer to flexibly spaced PuCGPy half-sites. Mol Cell Biol 1999; 19: 7741-7750.
101. Christensen J, Pedersen M, Aasted B, et al. Purification and characterization of the major nonstructural protein (NS-1) of Aleutian mink disease parvovirus. J Virol 1995; 69: 1802-1809.
102. Chung YH, Jun HS, Son M, et al. Cellular and molecular mechanism for Kilham rat virus-induced autoimmune diabetes in DR-BB rats. J Immunol 2000; 165: 2866-2876.
103. Clemens KE, Pintel DJ. The two transcription units of the autonomous parvovirus minute virus of mice are transcribed in a temporal order. J Virol 1988; 62: 1448-1451.
104. Cohen BJ, Buckley MM. The prevalence of antibody to human parvovirus B19 in England and Wales. J Med Microbiol 1988; 25: 151-153.
105. Cohen BJ, Field AM, Gudnadottir S, et al. Blood donor screening for parvovirus B19. J Virol Methods 1990; 30: 233-238.
106. Cohen S, Pante N. Pushing the envelope: microinjection of Minute virus of mice into Xenopus oocytes causes damage to the nuclear envelope. J Gen Virol 2005; 86: 3243-3252.
107. Corbau R, Duverger V, Rommelaere J, et al. Regulation of MVM NS1 by protein kinase C: impact of mutagenesis at consensus phosphorylation sites on replicative functions and cytopathic effects. Virology 2000; 278: 151-167.
108. Corbau R, Salom N, Rommelaere J, et al. Phosphorylation of the viral nonstructural protein NS1 during MVMp infection of A9 cells. Virology 1999; 259: 402-415.
109. Corcoran A, Doyle S. Advances in the biology, diagnosis and host-pathogen interactions of parvovirus B19. J Med Microbiol 2004; 53: 459-475.
110. Costello E, Saudan P, Winocour E, et al. High mobility group chromosomal protein 1 binds to the adeno-associated virus replication protein (Rep) and promotes Rep-mediated site-specific cleavage of DNA, ATPase activity and transcriptional repression. EMBO J 1997; 16: 5943-5954.
111. Cotmore SF, Christensen J, Nuesch JP, et al. The NS1 polypeptide of the murine parvovirus minute virus of mice binds to DNA sequences containing the motif [ACCA]2-3. J Virol 1995; 69: 1652-1660.
112. Cotmore SF, Christensen J, Tattersall P. Two widely spaced initiator binding sites create an HMG1-dependent parvovirus rolling-hairpin replication origin. J Virol 2000; 74: 1332-1341.
113. Cotmore SF, D'Abramo AM, Ticknor CM, et al. Controlled conformational transitions in the MVM virion expose the VP1 N-terminus and viral genome without particle disassembly. Virology 1999; 254: 169-181.
114. Cotmore SF, Hafenstein S, Tattersall P. Depletion of virion-associated divalent cations induces parvovirus minute virus of mice to eject its genome in a 3'-to-5' direction from an otherwise intact viral particle. J Virol 2010; 84: 1945-1956.
115. Cotmore SF, Sturzenbecker LJ, Tattersall P. The autonomous parvovirus minute virus of mice encodes 2 nonstructural proteins in addition to its capsid polypeptides. Virology 1983; 129: 333-343.
116. Cotmore SF, Tattersall P. A genome-linked copy of the NS-1 polypeptide is located on the outside of infectious parvovirus particles. J Virol 1989; 63: 3902-3911.
117. Cotmore SF, Tattersall P. DNA replication in the autonomous parvoviruses. Semin Virol 1995; 6: 271-281.
118. Cotmore SF, Tattersall P. Encapsidation of minute virus of mice DNA: aspects of the translocation mechanism revealed by the structure of partially packaged genomes. Virology 2005; 336: 100-112.
119. Cotmore SF, Tattersall P. Genome packaging sense is controlled by the efficiency of the nick site in the right-end replication origin of parvoviruses minute virus of mice and LuIII. J Virol 2005; 79: 2287-2300.
120. Cotmore SF, Tattersall P. High-mobility group 1/2 proteins are essential for initiating rolling- circle-type DNA replication at a parvovirus hairpin origin. J Virol 1998; 72: 8477-8484.
121. Cotmore SF, Tattersall P. Resolution of parvovirus dimer junctions proceeds through a novel heterocruciform intermediate. J Virol 2003; 77: 6245-6254.
122. Cotmore SF, Tattersall P. The autonomously replicating parvoviruses of vertebrates. Adv Virus Res 1987; 33: 91-174.
123. Cotmore SF, Tattersall P. The NS-1 polypeptide of minute virus of mice is covalently attached to the 5' termini of duplex replicative-form DNA and progeny single strands. J Virol 1988; 62: 851-860.
124. Csiza CK, Scott FW, De Lahunta A, et al. Pathogenesis of feline panleukopenia virus in susceptible newborn kittens I. Clinical signs, hematology, serology, and virology. Infect Immun 1971; 3: 833-837.
125. Csiza CK, Scott FW, De Lahunta A, et al. Respiratory signs and central nervous system lesions in cats infected with panleukopenia virus. A case report. Cornell Vet 1972; 62: 192-195.
126. Cutlip RC, Mengeling WL. Experimentally induced infection of neonatal swine with porcine parvovirus. Am J Vet Res 1975; 36: 1179-1182.
127. Cutlip RC, Mengeling WL. Pathogenesis of in utero infection: experimental infection of eight- and ten-week-old porcine fetuses with porcine parvovirus. Am J Vet Res 1975; 36: 1751-1754.
128. Cziepluch C, Lampel S, Grewenig A, et al. H-1 parvovirus-associated replication bodies: a distinct virus-induced nuclear structure. J Virol 2000; 74: 4807-4815.
129. D'Abramo AM Jr, Ali AA, Wang F, et al. Host range mutants of minute virus of mice with a single VP2 amino acid change require additional silent mutations that regulate NS2 accumulation. Virology 2005; 340: 143-154.
130. Davidson BL, Stein CS, Heth JA, et al. Recombinant adeno-associated virus type 2, 4, and 5 vectors: transduction of variant cell types and regions in the mammalian central nervous system. Proc Natl Acad Sci U S A 2000; 97: 3428-3432.
131. Davis C, Segev-Amzaleg N, Rotem I, et al. The P4 promoter of the parvovirus minute virus of mice is developmentally regulated in transgenic P4-LacZ mice. Virology 2003; 306: 268-279.
132. Davis MD, Wonderling RS, Walker SL, et al. Analysis of the effects of charge cluster mutations in adeno-associated virus Rep68 protein in vitro. J Virol 1999; 73: 2084-2093.
133. Davis MD, Wu J, Owens RA. Mutational analysis of adeno-associated virus type 2 Rep68 protein endonuclease activity on partially single-stranded substrates. J Virol 2000; 74: 2936-2942.
134. Deleu L, Fuks F, Spitkovsky D, et al. Opposite transcriptional effects of cyclic AMP-responsive elements in confluent or p27KIP-overexpressing cells versus serum-starved or growing cells. Mol Cell Biol 1998; 18: 409-419.
135. Deleu L, Pujol A, Faisst S, et al. Activation of promoter P4 of the autonomous parvovirus minute virus of mice at early S phase is required for productive infection. J Virol 1999; 73: 3877-3885.
136. Dettwiler S, Rommelaere J, Nuesch JP. DNA unwinding functions of minute virus of mice NS1 protein are modulated specifically by the lambda isoform of protein kinase C. J Virol 1999; 73: 7410-7420.
137. Ding W, Zhang L, Yan Z, et al. Intracellular trafficking of adeno-associated viral vectors. Gene Ther 2005; 12: 873-880.
138. Ding W, Zhang LN, Yeaman C, et al. rAAV2 traffics through both the late and the recycling endosomes in a dose-dependent fashion. Mol Ther 2006; 13: 671-682.
139. Doerig C, Hirt B, Antonietti JP, et al. Nonstructural protein of parvoviruses B19 and minute virus of mice controls transcription. J Virol 1990; 64: 387-396.
140. Doerig C, Hirt B, Beard P, et al. Minute virus of mice non-structural protein NS-1 is necessary and sufficient for trans-activation of the viral P39 promoter. J Gen Virol 1988; 69: 2563-2573.
141. Dorsch S, Kaufmann B, Schaible U, et al. The VP1-unique region of parvovirus B19: amino acid variability and antigenic stability. J Gen Virol 2001; 82: 191-199.
142. Dorsch S, Liebisch G, Kaufmann B, et al. The VP1 unique region of parvovirus B19 and its constituent phospholipase A2-like activity. J Virol 2002; 76: 2014-2018.
143. Duan D, Yue Y, Engelhardt JF. Expanding AAV packaging capacity with trans-splicing or overlapping vectors: a quantitative comparison. Mol Ther 2001; 4: 383-391.
144. Dubielzig R, King JA, Weger S, et al. Adeno-associated virus type 2 protein interactions: formation of pre-encapsidation complexes. J Virol 1999; 73: 8989-8998.
145. Dutheil N, Henckaerts E, Kohlbrenner E, et al. Transcriptional analysis of the adeno-associated virus integration site. J Virol 2009; 83: 12512-12525.
146. Dutheil N, Shi F, Dupressoir T, et al. Adeno-associated virus site-specifically integrates into a muscle-specific DNA region. Proc Natl Acad Sci U S A 2000; 97: 4862-4866.
147. Eichwald V, Daeffler L, Klein M, et al. The NS2 proteins of parvovirus minute virus of mice are required for efficient nuclear egress of progeny virions in mouse cells. J Virol 2002; 76: 10307-10319.
148. Ergaz Z, Ornoy A. Parvovirus B19 in pregnancy. Reprod Toxicol 2006; 21: 421-435.
149. Etingov I, Itah R, Mincberg M, et al. An extension of the Minute Virus of Mice tissue tropism. Virology 2008; 379: 245-255.
150. Farr GA, Tattersall P. A conserved leucine that constricts the pore through the capsid fivefold cylinder plays a central role in parvoviral infection. Virology 2004; 323: 243-256.
151. Farr GA, Zhang LG, Tattersall P. Parvoviral virions deploy a capsid-tethered lipolytic enzyme to breach the endosomal membrane during cell entry. Proc Natl Acad Sci U S A 2005; 102: 17148-17153.
152. Ferrarini M, Arsic N, Recchia FA, et al. Adeno-associated virus-mediated transduction of VEGF165 improves cardiac tissue viability and functional recovery after permanent coronary occlusion in conscious dogs. Circ Res 2006; 98: 954-961.
153. Forestier F, Tissot JD, Vial Y, et al. Haematological parameters of parvovirus B19 infection in 13 fetuses with hydrops foetalis. Br J Haematol 1999; 104: 925-927.
154. Fournier-Chambrillon C, Aasted B, Perrot A, et al. Antibodies to Aleutian mink disease parvovirus in free-ranging European mink (Mustela lutreola) and other small carnivores from southwestern France. J Wildl Dis 2004; 40: 394-402.
155. Fraefel C, Bittermann AG, Bueler H, et al. Spatial and temporal organization of adeno-associated virus DNA replication in live cells. J Virol 2004; 78: 389-398.
156. Franssila R, Hedman K. T-helper cell-mediated interferon-gamma, interleukin-10 and proliferation responses to a candidate recombinant vaccine for human parvovirus B19. Vaccine 2004; 22: 3809-3815.
157. Frickhofen N, Abkowitz JL, Safford M, et al. Persistent B19 parvovirus infection in patients infected with human immunodeficiency virus type 1 (HIV-1): a treatable cause of anemia in AIDS. Ann Intern Med 1990; 113: 926-933.
158. Frickhofen N, Young NS. Persistent parvovirus B19 infections in humans. Microb Pathog 1989; 7: 319-327.
159. Friedman-Einat M, Grossman Z, Mileguir F, et al. Detection of adeno-associated virus type 2 sequences in the human genital tract. J Clin Microbiol 1997; 35: 71-78.
160. Fuks F, Deleu L, Dinsart C, et al. ras oncogene-dependent activation of the P4 promoter of minute virus of mice through a proximal P4 element interacting with the Ets family of transcription factors. J Virol 1996; 70: 1331-1339.
161. Gaertner DJ, Smith AL, Jacoby RO. Efficient induction of persistent and prenatal parvovirus infection in rats. Virus Res 1996; 44: 67-78.
162. Gallinella G, Venturoli S, Manaresi E, et al. B19 virus genome diversity: epidemiological and clinical correlations. J Clin Virol 2003; 28: 1-13.
163. Gao G, Vandenberghe LH, Alvira MR, et al. Clades of adeno-associated viruses are widely disseminated in human tissues. J Virol 2004; 78: 6381-6388.
164. Garcia-Tapia AM, Fernandez-Gutierrez del Alamo C, Giron JA, et al. Spectrum of parvovirus B19 infection: analysis of an outbreak of 43 cases in Cadiz, Spain. Clin Infect Dis 1995; 21: 1424-1430.
165. Gavin DK, Young SM Jr, Xiao W, et al. Charge-to-alanine mutagenesis of the adeno-associated virus type 2 Rep78/68 proteins yields temperature-sensitive and magnesium-dependent variants. J Virol 1999; 73: 9433-9445.
166. Gay NJ, Hesketh LM, Cohen BJ, et al. Age specific antibody prevalence to parvovirus B19: how many women are infected in pregnancy? Commun Dis Rep CDR Rev 1994; 4: R104-R107.
167. Geoffroy MC, Epstein AL, Toublanc E, et al. Herpes simplex virus type 1 ICP0 protein mediates activation of adeno-associated virus type 2 rep gene expression from a latent integrated form. J Virol 2004; 78: 10977-10986.
168. Georg-Fries B, Biederlack S, Wolf J, et al. Analysis of proteins, helper dependence, and seroepidemiology of a new human parvovirus. Virology 1984; 134: 64-71.
169. Gillespie SM, Cartter ML, Asch S, et al. Occupational risk of human parvovirus B19 infection for school and day-care personnel during an outbreak of erythema infectiosum. J Am Med Assoc 1990; 263: 2061-2065.
170. Giraud C, Winocour E, Berns KI. Site-specific integration by adeno-associated virus is directed by a cellular DNA sequence. Proc Natl Acad Sci U S A 1994; 91: 10039-10043.
171. Girod A, Wobus CE, Zadori Z, et al. The VP1 capsid protein of adeno-associated virus type 2 is carrying a phospholipase A2 domain required for virus infectivity. J Gen Virol 2002; 83: 973-978.
172. Glavits R, Zolnai A, Szabo E, et al. Comparative pathological studies on domestic geese (Anser anser domestica) and Muscovy ducks (Cairina moschata) experimentally infected with parvovirus strains of goose and Muscovy duck origin. Acta Vet Hung 2005; 53: 73-89.
173. Govindasamy L, Hueffer K, Parrish CR, et al. Structures of host range-controlling regions of the capsids of canine and feline parvoviruses and mutants. J Virol 2003; 77: 12211-12221.
174. Green MR, Roeder RG. Definition of a novel promoter for the major adenovirus-associated virus mRNA. Cell 1980; 22: 231-242.
175. Green SW, Malkovska I, O'Sullivan MG, et al. Rhesus and pig-tailed macaque parvoviruses: identification of two new members of the erythrovirus genus in monkeys. Virology 2000; 269: 105-112.
176. Grieger JC, Samulski RJ. Packaging capacity of adeno-associated virus serotypes: impact of larger genomes on infectivity and postentry steps. J Virol 2005; 79: 9933-9944.
177. Grimm D, Kay MA. From virus evolution to vector revolution: use of naturally occurring serotypes of adeno-associated virus (AAV) as novel vectors for human gene therapy. Curr Gene Ther 2003; 3: 281-304.
178. Grossman Z, Mednelson E, Brok-Simoni F, et al. Detection of adeno-associated virus type 2 in human peripheral blood cells. J Gen Virol 1992; 73: 961-966.
179. Guan W, Cheng F, Huang Q, et al. Inclusion of the central exon of parvovirus B19 precursor mRNA is determined by multiple splicing enhancers in both the exon and the downstream intron. J Virol 2011; 85: 2463-2468.
180. Guan W, Cheng F, Yoto Y, et al. Block to the production of full-length B19 virus transcripts by internal polyadenylation is overcome by replication of the viral genome. J Virol 2008; 82: 9951-9963.
181. Ha Y, Lee YH, Ahn KK, et al. Reproduction of postweaning multisystemic wasting syndrome in pigs by prenatal porcine circovirus 2 infection and postnatal porcine parvovirus infection or immunostimulation. Vet Pathol 2008; 45: 842-848.
182. Hadlow WJ, Race RE, Kennedy RC. Comparative pathogenicity of four strains of aleutian disease virus for Pastel and Sapphire mink mustela vison. Infect Immun 1983; 41: 1016-1023.
183. Halbert CL, Rutledge EA, Allen JM, et al. Repeat transduction in the mouse lung by using adeno-associated virus vectors with different serotypes. J Virol 2000; 74: 1524-1532.
184. Halbert CL, Standaert TA, Aitken ML, et al. Transduction by adeno-associated virus vectors in the rabbit airway: efficiency, persistence, and readministration. J Virol 1997; 71: 5932-5941.
185. Han L, Parmley TH, Keith S, et al. High prevalence of adeno-associated virus (AAV) type 2 rep DNA in cervical materials: AAV may be sexually transmitted. Virus Genes 1996; 12: 47-52.
186. Hansen J, Qing K, Srivastava A. Adeno-associated virus type 2-mediated gene transfer: altered endocytic processing enhances transduction efficiency in murine fibroblasts. J Virol 2001; 75: 4080-4090.
187. Harbison CE, Lyi SM, Weichert WS, et al. Early steps in cell infection by parvoviruses: host-specific differences in cell receptor binding but similar endosomal trafficking. J Virol 2009; 83: 10504-10514.
188. Hasslung F, Wallgren P, Ladekjaer-Hansen AS, et al. Experimental reproduction of postweaning multisystemic wasting syndrome (PMWS) in pigs in Sweden and Denmark with a Swedish isolate of porcine circovirus type 2. Vet Microbiol 2005; 106: 49-60.
189. Hauck B, Xiao W. Characterization of tissue tropism determinants of adeno-associated virus type 1. J Virol 2003; 77: 2768-2774.
190. Hauswirth WW, Berns KI. Origin and termination of adeno-associated virus DNA replication. Virology 1977; 78: 488-499.
191. Henson JB, Leader RW, Gorham JR, et al. The sequential development of lesions in spontaneous Aleutian disease of mink. Pathol Vet 1966; 3: 289-314.
192. Hermonat PL. Inhibition of bovine papillomavirus DNA replication by adeno-associated virus. Virology 1992; 189: 329-333.
193. Hickman AB, Ronning DR, Perez ZN, et al. The nuclease domain of adeno-associated virus rep coordinates replication initiation using two distinct DNA recognition interfaces. Mol Cell 2004; 13: 403-414.
194. High K. Gene transfer for hemophilia: can therapeutic efficacy in large animals be safely translated to patients? J Thromb Haemost 2005; 3: 1682-1691.
195. High KA. Gene therapy for haemophilia: a long and winding road. J Thromb Haemost 2011; 9(Suppl 1): 2-11.
196. Hoggan MD, Blackow NR, Rowe WP. Studies of small DNA viruses found in various adenovirus preparations: physical, biological, and immunological characteristics. Proc Natl Acad Sci U S A 1966; 55: 1467-1474.
197. Hoggan MD, Thomas GF, Thomas FB, et al. Continuous "carriage" of adenovirus-associated virus genome in cell cultures in the absence of helped adenoviruses. Proceedings of the Fourth Lepetit Colloquium. Amsterdam: Elsivier/North Holland Publishing; 1972:243-249.
198. Hokynar K, Soderlund-Venermo M, Pesonen M, et al. A new parvovirus genotype persistent in human skin. Virology 2002; 302: 224-228.
199. Hoque M, Ishizu K-I, Matsumoto A, et al. Nuclear transport of the major capsid protein is essential for adeno-associated virus capsid formation. J Virol 1999; 73: 7912-7915.
200. Horer M, Weger S, Butz K, et al. Mutational analysis of adeno-associated virus Rep protein-mediated inhibition of heterologous and homologous promoters. J Virol 1995; 69: 5485-5496.
201. Hueffer K, Govindasamy L, Agbandje-McKenna M, et al. Combinations of two capsid regions controlling canine host range determine canine transferrin receptor binding by canine and feline parvoviruses. J Virol 2003; 77: 10099-10105.
202. Hueffer K, Parker JS, Weichert WS, et al. The natural host range shift and subsequent evolution of canine parvovirus resulted from virus-specific binding to the canine transferrin receptor. J Virol 2003; 77: 1718-1726.
203. Huser D, Gogol-Doring A, Lutter T, et al. Integration preferences of wildtype AAV-2 for consensus rep-binding sites at numerous loci in the human genome. PLoS Pathog 2010; 6: e1000985.
204. Ideno J, Mizukami H, Honda K, et al. Persistent phenotypic correction of central diabetes insipidus using adeno-associated virus vector expressing arginine-vasopressin in Brattleboro rats. Mol Ther 2003; 8: 895-902.
205. Ihalainen TO, Niskanen EA, Jylhava J, et al. Parvovirus induced alterations in nuclear architecture and dynamics. PLoS One 2009; 4: e5948.
206. Ilyina TV, Koonin EV. Conserved sequence motifs in the initiator proteins for rolling circle DNA replication encoded by diverse replicons from eubacteria, eucaryotes and archaebacteria. Nucleic Acids Res 1992; 20: 3279-3285.
207. Im DS, Muzyczka N. Factors that bind to adeno-associated virus terminal repeats. J Virol 1989; 63: 3095-3104.
208. Im DS, Muzyczka N. The AAV origin binding protein Rep68 is an ATP-dependent site-specific endonuclease with DNA helicase activity. Cell 1990; 61: 447-457.
209. Isa A, Kasprowicz V, Norbeck O, et al. Prolonged activation of virus-specific CD8+ T cells after acute B19 infection. PLoS Med 2005; 2: e343.
210. Ito S, Oyake T, Uchiyama T, et al. Successful treatment with cyclosporine and high-dose gamma immunoglobulin for persistent parvovirus B19 infection in a patient with refractory autoimmune hemolytic anemia. Int J Hematol 2004; 80: 250-253.
211. Jackson MK, Ellis LC, Morrey JD, et al. Progression of Aleutian disease in natural and experimentally induced infections of mink. Am J Vet Res 1996; 57: 1753-1758.
212. Jacobson SG, Cideciyan AV, Ratnakaram R, et al. Gene therapy for leber congenital amaurosis caused by RPE65 mutations: safety and efficacy in 15 children and adults followed up to 3 years. Arch Ophthalmol 2012; 130: 9-24.
213. Jacoby RO, Ball-Goodrich L, Paturzo FX, et al. Prevalence of rat virus infection in progeny of acutely or persistently infected pregnant rats. Comp Med 2001; 51: 38-42.
214. Jacoby RO, Ball-Goodrich LJ, Besselsen DG, et al. Rodent parvovirus infections. Lab Anim Sci 1996; 46: 370-380.
215. Jang MY, Yarborough OH 3rd, Conyers GB, et al. Stable secondary structure near the nicking site for adeno-associated virus type 2 Rep proteins on human chromosome 19. J Virol 2005; 79: 3544-3556.
216. Janus LM, Bleich A. Coping with parvovirus infections in mice: health surveillance and control. Lab Anim 2011:46:14-23
217. Jay FT, Laughlin CA, Carter BJ. Eukaryotic translational control: adeno-associated virus protein synthesis is affected by a mutation in the adenovirus DNA-binding protein. Proc Natl Acad Sci U S A 1981; 78: 2927-2931.
218. Jones MS, Kapoor A, Lukashov VV, et al. New DNA viruses identified in patients with acute viral infection syndrome. J Virol 2005; 79: 8230-8236.
219. Jongeneel CV, Sahli R, McMaster GK, et al. A precise map of splice junctions in the mRNAs of minute virus of mice, an autonomous parvovirus. J Virol 1986; 59: 564-573.
220. Joo HS, Donaldson-Wood CR, Johnson RH, et al. Pathogenesis of porcine parvovirus infection: pathology and immunofluorescence in the foetus. J Comp Pathol 1977; 87: 383-391.
221. Jordan J, Tiangco B, Kiss J, et al. Human parvovirus B19: prevalence of viral DNA in volunteer blood donors and clinical outcomes of transfusion recipients. Vox Sang 1998; 75: 97-102.
222. Kapoor A, Simmonds P, Lipkin WI. Discovery and characterization of mammalian endogenous parvoviruses. J Virol 2010; 84: 12628-12635.
223. Kapoor A, Simmonds P, Slikas E, et al. Human bocaviruses are highly diverse, dispersed, recombination prone, and prevalent in enteric infections. J Infect Dis 2010; 201: 1633-1643.
224. Kapoor A, Slikas E, Simmonds P, et al. A newly identified bocavirus species in human stool. J Infect Dis 2009; 199: 196-200.
225. Kasprowicz V, Isa A, Tolfvenstam T, et al. Tracking of peptide-specific CD4+ T-cell responses after an acute resolving viral infection: a study of parvovirus B19. J Virol 2006; 80: 11209-11217.
226. Katzourakis A, Gifford RJ. Endogenous viral elements in animal genomes. PLoS Genet 2010; 6: e1001191.
227. Kaufmann B, Baxa U, Chipman PR, et al. Parvovirus B19 does not bind to membrane-associated globoside in vitro. Virology 2005; 332: 189-198.
228. Kaufmann B, Bowman VD, Li Y, et al. Structure of Penaeus stylirostris densovirus, a shrimp pathogen. J Virol 2010; 84: 11289-11296.
229. Kaufmann B, Simpson AA, Rossmann MG. The structure of human parvovirus B19. Proc Natl Acad Sci U S A 2004; 101: 11628-11633.
230. Kearns WG, Afione SA, Fulmer SB, et al. Recombinant adeno-associated virus (AAV-CFTR) vectors do not integrate in a site-specific fashion in an immortalized epithelial cell line. Gene Ther 1996; 3: 748-755.
231. Kern A, Schmidt K, Leder C, et al. Identification of a heparin-binding motif on adeno-associated virus type 2 capsids. J Virol 2003; 77: 11072-11081.
232. Kilham L, Margolis G, Colby ED. Congenital infections of cats and ferrets by feline panleukopenia virus manifested by cerebella hypoplasia. Lab Invest 1967; 17: 465-480.
233. Kilham L, Oliver LJ. A latent virus of rats isolated in tissue culture. Virology 1959; 7: 428-437.
234. King AMQ, Adams MJ, Carstens EB, et al, eds. Virus Taxonomy: Classification and Nomenclature of Viruses: Ninth Report of the International Committee on Taxonomy of Viruses. San Diego: Elsevier Academic Press; 2011.
235. Kirik D, Georgievska B, Burger C, et al. Reversal of motor impairments in parkinsonian rats by continuous intrastriatal delivery of L-dopa using rAAV-mediated gene transfer. Proc Natl Acad Sci U S A 2002; 99: 4708-4713.
236. Kisary J. Some growth characteristics of goose parvovirus strain "B." Acta Vet Acad Sci Hung 1974; 24: 329-333.
237. Kleinman SH, Glynn SA, Lee TH, et al. A linked donor-recipient study to evaluate parvovirus B19 transmission by blood component transfusion. Blood 2009; 114: 3677-3683.
238. Kleinschmidt JA, Mohler M, Weindler FW, et al. Sequence elements of the adeno-associated virus rep gene required for suppression of herpes-simplex-virus-induced DNA amplification. Virology 1995; 206: 254-262.
239. Koch WC, Adler SP. Human parvovirus B19 infections in women of childbearing age and within families. Pediatr Infect Dis J 1989; 8: 83-87.
240. Kontou M, Govindasamy L, Nam HJ, et al. Structural determinants of tissue tropism and in vivo pathogenicity for the parvovirus minute virus of mice. J Virol 2005; 79: 10931-10943.
241. Koppelman MH, van Swieten P, Cuijpers HT. Real-time polymerase chain reaction detection of parvovirus B19 DNA in blood donations using a commercial and an in-house assay. Transfusion 2011; 51: 1346-1354.
242. Kotin RM, Linden RM, Berns KI. Characterization of a preferred site on human chromosome 19q for integration of adeno-associated virus DNA by non-homologous recombination. EMBO J 1992; 11: 5071-5078.
243. Kotin RM, Menninger JC, Ward DC, et al. Mapping and direct visualization of a region-specific viral DNA integration site on chromosome 19q13-qter. Genomics 1991; 10: 831-834.
244. Kotin RM, Siniscalco M, Samulski RJ, et al. Site-specific integration by adeno-associated virus. Proc Natl Acad Sci U S A 1990; 87: 2211-2215.
245. Krady JK, Ward DC. Transcriptional activation by the parvoviral nonstructural protein NS-1 is mediated via a direct interaction with Sp1. Mol Cell Biol 1995; 15: 524-533.
246. Kresse JI, Taylor WD, Stewart WW, et al. Parvovirus infection in pigs with necrotic and vesicle-like lesions. Vet Microbiol 1985; 10: 525-531.
247. Kronenberg S, Bottcher B, von der Lieth CW, et al. A conformational change in the adeno-associated virus type 2 capsid leads to the exposure of hidden VP1 N termini. J Virol 2005; 79: 5296-5303.
248. Kurpad C, Mukherjee P, Wang XS, et al. Adeno-associated virus 2-mediated transduction and erythroid lineage-restricted expression from parvovirus B19p6 promoter in primary human hematopoietic progenitor cells. J Hematother Stem Cell Res 1999; 8: 585-592.
249. Kurtzman G, Frickhofen N, Kimball J, et al. Pure red-cell aplasia of 10 years' duration due to persistent parvovirus B19 infection and its cure with immunoglobulin therapy. N Engl J Med 1989; 321: 519-523.
250. Kurtzman GJ, Cohen BJ, Field AM, et al. Immune response to B19 parvovirus and an antibody defect in persistent viral infection. J Clin Invest 1989; 84: 1114-1123.
251. Kurtzman GJ, Gascon P, Caras M, et al. B19 parvovirus replicates in circulating cells of acutely infected patients. Blood 1988; 71: 1448-1454.
252. Kurtzman GJ, Ozawa K, Cohen B, et al. Chronic bone marrow failure due to persistent B19 parvovirus infection. N Engl J Med 1987; 317: 287-294.
253. Kyostio SR, Wonderling RS, Owens RA. Negative regulation of the adeno-associated virus (AAV) P5 promoter involves both the P5 rep binding site and the consensus ATP-binding motif of the AAV Rep68 protein. J Virol 1995; 69: 6787-6796.
254. Labow MA, Hermonat PL, Berns KI. Positive and negative autoregulation of the adeno-associated virus type 2 genome. J Virol 1986; 60: 251-258.
255. Lachmann S, Rommeleare J, Nuesch JP. Novel PKCeta is required to activate replicative functions of the major nonstructural protein NS1 of minute virus of mice. J Virol 2003; 77: 8048-8060.
256. Lai Y, Yue Y, Liu M, et al. Efficient in vivo gene expression by trans-splicing adeno-associated viral vectors. Nat Biotechnol 2005; 23: 1435-1439.
257. Langeveld JP, Casal JI, Cortes E, et al. Effective induction of neutralizing antibodies with the amino terminus of VP2 of canine parvovirus as a synthetic peptide. Vaccine 1994; 12: 1473-1480.
258. Langeveld JP, Casal JI, Osterhaus AD, et al. First peptide vaccine providing protection against viral infection in the target animal: studies of canine parvovirus in dogs. J Virol 1994; 68: 4506-4513.
259. Larochelle R, Magar R, D'Allaire S. Comparative serologic and virologic study of commercial swine herds with and without postweaning multisystemic wasting syndrome. Can J Vet Res 2003; 67: 114-120.
260. Laughlin CA, Westphal H, Carter BJ. Spliced adenovirus-associated virus RNA. Proc Natl Acad Sci U S A 1979; 76: 5567-5571.
261. Lenghaus C, Studdert MJ. Acute and chronic viral myocarditis. Acute diffuse nonsuppurative myocarditis and residual myocardial scarring following infection with canine parvovirus. Am J Pathol1984;115:316-319.
262. Lenghaus C, Studdert MJ, Finnie JW. Acute and chronic canine parvovirus myocarditis following intrauterine inoculation. Aust Vet J 1980; 56: 465-468.
263. Li L, Pesavento PA, Woods L, et al. Novel amdovirus in gray foxes. Emerg Infect Dis 2011; 17: 1876-1878.
264. Li X, Rhode SL. Nonstructural protein NS2 of parvovirus H-1 is required for efficient viral protein synthesis and virus production in rat cells in vivo and in vitro. Virology 1991; 184: 117-130.
265. Linden RM, Winocour E, Berns KI. The recombination signals for adeno-associated virus site-specific integration. Proc Natl Acad Sci U S A 1996; 93: 7966-7972.
266. Linser P, Bruning H, Armentrout RW. Uptake of minute virus of mice into cultured rodent cells. J Virol 1979; 31: 537-545.
267. Liu H, Fu Y, Xie J, et al. Widespread endogenization of densoviruses and parvoviruses in animal and human genomes. J Virol 2011; 85: 9863-9876.
268. Lochrie MA, Tatsuno GP, Christie B, et al. Mutations on the external surfaces of adeno-associated virus type 2 capsids that affect transduction and neutralization. J Virol 2006; 80: 821-834.
269. Lombardo E, Ramírez JC, Agbandje-McKenna M, et al. A beta-stranded motif drives capsid protein oligomers of the parvovirus minute virus of mice into the nucleus for viral assembly. J Virol 2000; 74: 3804-3814.
270. Lombardo E, Ramirez JC, Garcia J, et al. Complementary roles of multiple nuclear targeting signals in the capsid proteins of the parvovirus minute virus of mice during assembly and onset of infection. J Virol 2002; 76: 7049-7059.
271. Lopez de Turiso JA, Cortes E, Martinez C, et al. Recombinant vaccine for canine parvovirus in dogs. J Virol 1992; 66: 2748-2753.
272. Lopez-Bueno A, Mateu MG, Almendral JM. High mutant frequency in populations of a DNA virus allows evasion from antibody therapy in an immunodeficient host. J Virol 2003; 77: 2701-2708.
273. Lopez-Bueno A, Rubio MP, Bryant N, et al. Host-selected amino acid changes at the sialic acid binding pocket of the parvovirus capsid modulate cell binding affinity and determine virulence. J Virol 2006; 80: 1563-1573.
274. Lopez-Bueno A, Segovia JC, Bueren JA, et al. Evolution to pathogenicity of the parvovirus minute virus of mice in immunodeficient mice involves genetic heterogeneity at the capsid domain that determines tropism. J Virol 2008; 82: 1195-1203.
275. Lopez-Bueno A, Valle N, Gallego JM, et al. Enhanced cytoplasmic sequestration of the nuclear export receptor CRM1 by NS2 mutations developed in the host regulates parvovirus fitness. J Virol 2004; 78: 10674-10684.
276. Lopez-Bueno A, Villarreal LP, Almendral JM. Parvovirus variation for disease: a difference with RNA viruses? Curr Top Microbiol Immunol 2006; 299: 349-370.
277. Lorson C, Burger LR, Mouw M, et al. Efficient transactivation of the minute virus of mice P38 promoter requires upstream binding of NS1. J Virol 1996; 70: 834-842.
278. Lorson C, Pearson J, Burger L, et al. An Sp1-binding site and TATA element are sufficient to support full transactivation by proximally bound NS1 protein of minute virus of mice. Virology 1998; 240: 326-337.
279. Lu Y, Choi YK, Campbell-Thompson M, et al. Therapeutic level of functional human alpha 1 antitrypsin (hAAT) secreted from murine muscle transduced by adeno-associated virus (rAAV1) vector. J Gene Med 2006; 8: 730-735.
280. Lukashov VV, Goudsmit J. Evolutionary relationships among parvoviruses: virus-host coevolution among autonomous primate parvoviruses and links between adeno- associated and avian parvoviruses. J Virol 2001; 75: 2729-2740.
281. Lusby E, Fife KH, Berns KI. Nucleotide sequence of the inverted terminal repetition in adeno-associated virus DNA. J Virol 1980; 34: 402-409.
282. Lusby EW, Berns KI. Mapping of the 5' termini of two adeno-associated virus 2 RNAs in the left half of the genome. J Virol 1982; 41: 518-526.
283. Macartney L, McCandlish IA, Thompson H, et al. Canine parvovirus enteritis 1: clinical, haematological and pathological features of experimental infection. Vet Rec 1984; 115: 201-210.
284. Macartney L, McCandlish IA, Thompson H, et al. Canine parvovirus enteritis 2: pathogenesis. Vet Rec 1984; 115: 453-460.
285. Macartney L, McCandlish IA, Thompson H, et al. Canine parvovirus enteritis 3: scanning electron microscopical features of experimental infection. Vet Rec 1984; 115: 533-537.
286. Mah C, Qing K, Khuntirat B, et al. Adeno-associated virus type 2-mediated gene transfer: role of epidermal growth factor receptor protein tyrosine kinase in transgene expression. J Virol 1998; 72: 9835-9843.
287. Martella V, Cavalli A, Pratelli A, et al. A canine parvovirus mutant is spreading in Italy. J Clin Microbiol 2004; 42: 1333-1336.
288. McCarty DM, Christensen M, Muzyczka N. Sequences required for coordinate induction of adeno-associated virus p19 and p40 promoters by Rep protein. J Virol 1991; 65: 2936-2945.
289. McCarty DM, Ni TH, Muzyczka N. Analysis of mutations in adeno-associated virus Rep protein in vivo and in vitro. J Virol 1992; 66: 4050-4057.
290. McCarty DM, Pereira DJ, Zolotukhin I, et al. Identification of linear DNA sequences that specifically bind the adeno-associated virus Rep protein. J Virol 1994; 68: 4988-4997.
291. McKenna R, Olson NH, Chipman PR, et al. Three-dimensional structure of Aleutian mink disease parvovirus: implications for disease pathogenicity. J Virol 1999; 73: 6882-6891.
292. McKisic MD, Paturzo FX, Gaertner DJ, et al. A nonlethal rat parvovirus infection suppresses rat T lymphocyte effector functions. J Immunol 1995; 155: 3979-3986.
293. McLaughlin SK, Collis P, Hermonat PL, et al. Adeno-associated virus general transduction vectors: analysis of proviral structures. J Virol 1988; 62: 1963-1973.
294. McOmish F, Yap PL, Jordan A, et al. Detection of parvovirus B19 in donated blood: a model system for screening by polymerase chain reaction. J Clin Microbiol 1993; 31: 323-328.
295. Mendelson E, Trempe JP, Carter BJ. Identification of the trans-acting Rep proteins of adeno-associated virus by antibodies to a synthetic oligopeptide. J Virol 1986; 60: 823-832.
296. Meneses P, Berns KI, Winocour E. DNA sequence motifs which direct adeno-associated virus site-specific integration in a model system. J Virol 2000; 74: 6213-6216.
297. Mengeling WL, Cutlip RC. Pathogenesis of in utero infection: experimental infection of five-week-old porcine fetuses with porcine parvovirus. Am J Vet Res 1975; 36: 1173-1177.
298. Meunier PC, Cooper BJ, Appel MJ, et al. Pathogenesis of canine parvovirus enteritis: the importance of viremia. Vet Pathol 1985; 22: 60-71.
299. Meunier PC, Cooper BJ, Appel MJ, et al. Pathogenesis of canine parvovirus enteritis: sequential virus distribution and passive immunization studies. Vet Pathol 1985; 22: 617-624.
300. Mishra L, Rose JA. Adeno-associated virus DNA replication is induced by genes that are essential for HSV-1 DNA synthesis. Virology 1990; 179: 632-639.
301. Mochizuki M, Hashimoto M, Hajima T, et al. Virologic and serologic identification of minute virus of canines (canine parvovirus type 1) from dogs in Japan. J Clin Microbiol 2002; 40: 3993-3998.
302. Morey AL, Fleming KA. Immunophenotyping of fetal haemopoietic cells permissive for human parvovirus B19 replication in vitro. Br J Haematol 1992; 82: 302-309.
303. Morey AL, Porter HJ, Keeling JW, et al. Non-isotopic in situ hybridisation and immunophenotyping of infected cells in the investigation of human fetal parvovirus infection. J Clin Pathol 1992; 45: 673-678.
304. Morgan WR, Ward DC. Three splicing patterns are used to excise the small intron common to all minute virus of mice RNAs. J Virol 1986; 60: 1170-1174.
305. Mori K, Gehlbach P, Yamamoto S, et al. AAV-mediated gene transfer of pigment epithelium-derived factor inhibits choroidal neovascularization. Invest Ophthalmol Vis Sci 2002; 43: 1994-2000.
306. Muralidhar S, Becerra SP, Rose JA. Site-directed mutagenesis of adeno-associated virus type 2 structural protein initiation codons: effects on regulation of synthesis and biological activity. J Virol 1994; 68: 170-176.
307. Musiani M, Manaresi E, Gallinella G, et al. Immunoreactivity against linear epitopes of parvovirus B19 structural proteins. Immunodominance of the amino-terminal half of the unique region of VP1. J Med Virol 2000; 60: 347-352.
308. Muzyczka N, Warrington KH Jr. Custom adeno-associated virus capsids: the next generation of recombinant vectors with novel tropism. Hum Gene Ther 2005; 16: 408-416.
309. Naeger LK, Cater J, Pintel DJ. The small nonstructural protein (NS2) of the parvovirus minute virus of mice is required for efficient DNA replication and infectious virus production in a cell-type-specific manner. J Virol 1990; 64: 6166-6175.
310. Nakamura M, Tohya Y, Miyazawa T, et al. A novel antigenic variant of canine parvovirus from a Vietnamese dog. Arch Virol 2004; 149: 2261-2269.
311. Nam HJ, Gurda-Whitaker B, Gan WY, et al. Identification of the sialic acid structures recognized by minute virus of mice and the role of binding affinity in virulence adaptation. J Biol Chem 2006; 281: 25670-25677.
312. Nash K, Chen W, Muzyczka N. Complete in vitro reconstitution of adeno-associated virus DNA replication requires the minichromosome maintenance complex proteins. J Virol 2008; 82: 1458-1464.
313. Ni TH, McDonald WF, Zolotukhin I, et al. Cellular proteins required for adeno-associated virus DNA replication in the absence of adenovirus coinfection. J Virol 1998; 72: 2777-2787.
314. Nicolas A, Alazard-Dany N, Biollay C, et al. Identification of rep-associated factors in herpes simplex virus type 1-induced adeno-associated virus type 2 replication compartments. J Virol 2010; 84: 8871-8887.
315. Nigro G, D'Eufemia P, Zerbini M, et al. Parvovirus B19 infection in a hypogammaglobulinemic infant with neurologic disorders and anemia: successful immunoglobulin therapy. Pediatr Infect Dis J 1994; 13: 1019-1021.
316. Nuesch JP, Christensen J, Rommelaere J. Initiation of minute virus of mice DNA replication is regulated at the level of origin unwinding by atypical protein kinase C phosphorylation of NS1. J Virol 2001; 75: 5730-5739.
317. Nuesch JP, Cotmore SF, Tattersall P. Sequence motifs in the replicator protein of parvovirus MVM essential for nicking and covalent attachment to the viral origin: identification of the linking tyrosine. Virology 1995; 209: 122-135.
318. Nuesch JP, Dettwiler S, Corbau R, et al. Replicative functions of minute virus of mice NS1 protein are regulated in vitro by phosphorylation through protein kinase C. J Virol 1998; 72: 9966-9977.
319. Nuesch JP, Lachmann S, Corbau R, et al. Regulation of minute virus of mice NS1 replicative functions by atypical PKClambda in vivo. J Virol 2003; 77: 433-442.
320. Nuesch JPF, Tattersall P. Nuclear targeting of the parvoviral replicator molecule NS1: evidence for self-association prior to nuclear translocation. Virology 1993; 196: 637-651.
321. Oie KL, Durrant G, Wolfinbarger JB, et al. The relationship between capsid protein (VP2) sequence and pathogenicity of Aleutian mink disease parvovirus (ADV): a possible role for raccoons in the transmission of ADV infections. J Virol 1996; 70: 852-861.
322. Olofsson A, Mittelholzer C, Treiberg Berndtsson L, et al. Unusual, high genetic diversity of Aleutian mink disease virus. J Clin Microbiol 1999; 37: 4145-4149.
323. Oraveerakul K, Choi CS, Molitor TW. Tissue tropisms of porcine parvovirus in swine. Arch Virol 1993; 130: 377-389.
324. O'Sullivan MG, Anderson DC, Fikes JD, et al. Identification of a novel simian parvovirus in cynomolgus monkeys with severe anemia. A paradigm of human B19 parvovirus infection. J Clin Invest 1994; 93: 1571-1576.
325. O'Sullivan MG, Anderson DK, Goodrich JA, et al. Experimental infection of cynomolgus monkeys with simian parvovirus. J Virol 1997; 71: 4517-4521.
326. O'Sullivan MG, Anderson DK, Lund JE, et al. Clinical and epidemiological features of simian parvovirus infection in cynomolgus macaques with severe anemia. Lab Anim Sci 1996; 46: 291-297.
327. Owens RA, Weitzman MD, Kyostio SR, et al. Identification of a DNA-binding domain in the amino terminus of adeno-associated virus Rep proteins. J Virol 1993; 67: 997-1005.
328. Ozawa K, Ayub J, Yu-Shu H, et al. Novel transcription map for the B19 (human) pathogenic parvovirus. J Virol 1987; 61: 2395-2406.
329. Ozawa K, Kurtzman G, Young N. Productive infection by B19 parvovirus of human erythroid bone marrow cells in vitro. Blood 1987; 70: 384-391.
330. Ozawa K, Kurtzman G, Young N. Replication of the B19 parvovirus in human bone marrow cell cultures. Science 1986; 233: 883-886.
331. Palermo LM, Hueffer K, Parrish CR. Residues in the apical domain of the feline and canine transferrin receptors control host-specific binding and cell infection of canine and feline parvoviruses. J Virol 2003; 77: 8915-8923.
332. Parker JS, Murphy WJ, Wang D, et al. Canine and feline parvoviruses can use human or feline transferrin receptors to bind, enter, and infect cells. J Virol 2001; 75: 3896-3902.
333. Parker JS, Parrish CR. Canine parvovirus host range is determined by the specific conformation of an additional region of the capsid. J Virol 1997; 71: 9214-9222.
334. Parker JS, Parrish CR. Cellular uptake and infection by canine parvovirus involves rapid dynamin-regulated clathrin-mediated endocytosis, followed by slower intracellular trafficking. J Virol 2000; 74: 1919-1930.
335. Parks WP, Green M, Pina M, et al. Physicochemical characterization of adeno-associated satellite virus type 4 and its nucleic acid. J Virol 1967; 1: 980-987.
336. Parrish CR. Pathogenesis of feline panleukopenia virus and canine parvovirus. Baillieres Clin Haematol 1995; 8: 57-71.
337. Parrish CR. Structures and functions of parvovirus capsids and the process of cell infection. Curr Top Microbiol Immunol 2010; 343: 149-176.
338. Parrish CR, Aquadro C, Strassheim ML, et al. Rapid antigenic-type replacement and DNA sequence evolution of canine parvovirus. J Virol 1991; 65: 6544-6552.
339. Parrish CR, Carmichael LE. Antigenic structure and variation of canine parvovirus type-2, feline panleukopenia virus, and mink enteritis virus. Virology 1983; 129: 401-414.
340. Parrish CR, Kawaoka Y. The origins of new pandemic viruses: the acquisition of new host ranges by canine parvovirus and influenza A viruses. Annu Rev Microbiol 2005; 59: 553-586.
341. Paul PS, Mengeling WL. Oronasal and intramuscular vaccination of swine with a modified live porcine parvovirus vaccine: multiplication and transmission of the vaccine virus. Am J Vet Res 1984; 45: 2481-2485.
342. Paul PS, Mengeling WL, Brown TT Jr. Effect of vaccinal and passive immunity on experimental infection of pigs with porcine parvovirus. Am J Vet Res 1980; 41: 1368-1371.
343. Peel AL, Zolotukhin S, Schrimsher GW, et al. Efficient transduction of green fluorescent protein in spinal cord neurons using adeno-associated virus vectors containing cell type-specific promoters. Gene Ther 1997; 4: 16-24.
344. Perabo L, Buning H, Kofler DM, et al. In vitro selection of viral vectors with modified tropism: the adeno-associated virus display. Mol Ther 2003; 8: 151-157.
345. Pereira DJ, McCarty DM, Muzyczka N. The adeno-associated virus (AAV) Rep protein acts as both a repressor and an activator to regulate AAV transcription during a productive infection. J Virol 1997; 71: 1079-1088.
346. Perros M, Deleu L, Vanacker JM, et al. Upstream CREs participate in the basal activity of minute virus of mice promoter P4 and in its stimulation in ras-transformed cells. J Virol 1995; 69: 5506-5515.
347. Philpott NJ, Gomos J, Berns KI, et al. A p5 integration efficiency element mediates Rep-dependent integration into AAVS1 at chromosome 19. Proc Natl Acad Sci U S A 2002; 99: 12381-12385.
348. Pintel D, Dadachanji D, Astell CR, et al. The genome of minute virus of mice, an autonomous parvovirus, encodes two overlapping transcription units. Nucleic Acids Res 1983; 11: 1019-1038.
349. Plentz A, Hahn J, Knoll A, et al. Exposure of hematologic patients to parvovirus B19 as a contaminant of blood cell preparations and blood products. Transfusion 2005; 45: 1811-1815.
350. Plevka P, Hafenstein S, Li L, et al. Structure of a packaging-defective mutant of minute virus of mice indicates that the genome is packaged via a pore at a 5-fold axis. J Virol 2011; 85: 4822-4827.
351. Plummer FA, Hammond GW, Forward K, et al. An erythema infectiosum-like illness caused by human parvovirus infection. N Engl J Med 1985; 313: 74-79.
352. Pollock RVH, Carmichael LE. Maternally derived immunity to canine parvovirus infection: transfer, decline and interference with vaccination. J Am Vet Med Assoc 1982; 180: 37-42.
353. Ponnazhagan S, Mahendra G, Kumar S, et al. Conjugate-based targeting of recombinant adeno-associated virus type 2 vectors by using avidin-linked ligands. J Virol 2002; 76: 12900-12907.
354. Porter DD. Aleutian disease: a persistent parvovirus infection of mink with a maximal but ineffective host humoral immune response. Prog Med Virol 1986; 33: 42-60.
355. Porter HJ, Quantrill AM, Fleming KA. B19 parvovirus infection of myocardial cells. Lancet 1988; 1: 535-536.
356. Potter CG, Potter AC, Hatton CS, et al. Variation of erythroid and myeloid precursors in the marrow and peripheral blood of volunteer subjects infected with human parvovirus (B19). J Clin Invest 1987; 79: 1486-1492.
357. Prasad KM, Trempe JP. The adeno-associated virus Rep78 protein is covalently linked to viral DNA in a preformed virion. Virology 1995; 214: 360-370.
358. Pujol A, Deleu L, Nuesch JP, et al. Inhibition of parvovirus minute virus of mice replication by a peptide involved in the oligomerization of nonstructural protein NS1. J Virol 1997; 71: 7393-7403.
359. Qing K, Mah C, Hansen J, et al. Human fibroblast growth factor receptor 1 is a co-receptor for infection by adeno-associated virus 2. Nat Med 1999; 5: 71-77.
360. Qing K, Wang XS, Kube DM, et al. Role of tyrosine phosphorylation of a cellular protein in adeno-associated virus 2-mediated transgene expression. Proc Natl Acad Sci U S A 1997; 94: 10879-10884.
361. Qiu J, Cheng F, Burger LR, et al. The transcription profile of Aleutian mink disease virus in CRFK cells is generated by alternative processing of pre-mRNAs produced from a single promoter. J Virol 2006; 80: 654-662.
362. Qiu J, Nayak R, Tullis GE, et al. Characterization of the transcription profile of adeno-associated virus type 5 reveals a number of unique features compared to previously characterized adeno-associated viruses. J Virol 2002; 76: 12435-12447.
363. Qiu J, Pintel D. Processing of adeno-associated virus RNA. Front Biosci 2008; 13: 3101-3115.
364. Qiu J, Pintel DJ. The adeno-associated virus type 2 Rep protein regulates RNA processing via interaction with the transcription template. Mol Cell Biol 2002; 22: 3639-3652.
365. Recchia A, Mavilio F. Site-specific integration by the adeno-associated virus rep protein. Curr Gene Ther 2011; 11: 399-405.
366. Recchia A, Perani L, Sartori D, et al. Site-specific integration of functional transgenes into the human genome by adeno/AAV hybrid vectors. Mol Ther 2004; 10: 660-670.
367. Rhode SL. trans-Activation of parvovirus P38 promoter by the 76K noncapsid protein. J Virol 1985; 55: 886-889.
368. Rhode SL, Paradiso PR. Parvovirus genome: nucleotide sequence of H-1 and mapping of its genes by hybrid arrested translation. J Virol 1983; 45: 173-184.
369. Rhode SLI. Replication process of the parvovirus H-1 I. Kinetics in a parasynchronous cell system. J Virol1973;11:856-861.
370. Richardson WD, Westphal H. A cascade of adenovirus early functions is required for expression of adeno-associated virus. Cell 1981; 27: 133-141.
371. Ried MU, Girod A, Leike K, et al. Adeno-associated virus capsids displaying immunoglobulin-binding domains permit antibody-mediated vector retargeting to specific cell surface receptors. J Virol 2002; 76: 4559-4566.
372. Riolobos L, Reguera J, Mateu MG, et al. Nuclear transport of trimeric assembly intermediates exerts a morphogenetic control on the icosahedral parvovirus capsid. J Mol Biol 2006; 357: 1026-1038.
373. Ros C, Burckhardt CJ, Kempf C. Cytoplasmic trafficking of minute virus of mice: low-pH requirement, routing to late endosomes, and proteasome interaction. J Virol 2002; 76: 12634-12645.
374. Ros C, Kempf C. The ubiquitin-proteasome machinery is essential for nuclear translocation of incoming minute virus of mice. Virology 2004; 324: 350-360.
375. Rosenfeld SJ, Yoshimoto K, Kajigaya S, et al. Unique region of the minor capsid protein of human parvovirus B19 is exposed on the virion surface. J Clin Invest 1992; 89: 2023-2029.
376. Rubio MP, Lopez-Bueno A, Almendral JM. Virulent variants emerging in mice infected with the apathogenic prototype strain of the parvovirus minute virus of mice exhibit a capsid with low avidity for a primary receptor. J Virol 2005; 79: 11280-11290.
377. Ruffing M, Zentgraf H, Kleinschmidt JA. Assembly of viruslike particles by recombinant structural proteins of adeno-associated virus type 2 in insect cells. J Virol 1992; 66: 6922-6930.
378. Ruiz Z, Mihaylov IS, Cotmore SF, et al. Recruitment of DNA replication and damage response proteins to viral replication centers during infection with NS2 mutants of Minute Virus of Mice (MVM). Virology 2011; 410: 375-384.
379. Rutledge EA, Halbert CL, Russell DW. Infectious clones and vectors derived from adeno-associated virus (AAV) serotypes other than AAV type 2. J Virol 1998; 72: 309-319.
380. Ryan JH, Zolotukhin S, Muzyczka N. Sequence requirements for binding of Rep68 to the adeno-associated virus terminal repeats. J Virol 1996; 70: 1542-1553.
381. Saikawa T, Anderson S, Momoeda M, et al. Neutralizing linear epitopes of B19 parvovirus cluster in the VP1 unique and VP1-VP2 junction regions. J Virol 1993; 67: 3004-3009.
382. Salvino R, Skiadopoulos M, Faust EA, et al. Two spatially distinct genetic elements constitute a bipartite DNA replication origin in the minute virus of mice genome. J Virol 1991; 65: 1352-1363.
383. Samulski RJ, Zhu X, Xiao X, et al. Targeted integration of adeno-associated virus (AAV) into human chromosome 19. EMBO J 1991; 10: 3941-3950.
384. Sanlioglu S, Benson PK, Yang J, et al. Endocytosis and nuclear trafficking of adeno-associated virus type 2 are controlled by rac1 and phosphatidylinositol-3 kinase activation. J Virol 2000; 74: 9184-9196.
385. Sato H, Hirata J, Kuroda N, et al. Identification and mapping of neutralizing epitopes of human parvovirus B19 by using human antibodies. J Virol 1991; 65: 5485-5490.
386. Schlehofer JR, Ehrbar M, zur Hausen H. Vaccinia virus, herpes simplex virus, and carcinogens induce DNA amplification in a human cell line and support replication of a helpervirus dependent parvovirus. Virology 1986; 152: 110-117.
387. Schmidt M, Grot E, Cervenka P, et al. Identification and characterization of novel adeno-associated virus isolates in ATCC virus stocks. J Virol 2006; 80: 5082-5085.
388. Schmidt OW, Cooney MK, Foy HM. Adeno-associated virus in adenovirus type 3 conjunctivitis. Infect Immun 1975; 11: 1362-1370.
389. Schwartz D, Green B, Carmichael LE, et al. The canine minute virus (minute virus of canines) is a distinct parvovirus that is most similar to bovine parvovirus. Virology 2002; 302: 219-223.
390. Schwartz RA, Carson CT, Schuberth C, et al. Adeno-associated virus replication induces a DNA damage response coordinated by DNA-PK. J Virol 2009; 83: 6269-6278.
391. Servant A, Laperche S, Lallemand F, et al. Genetic diversity within human erythroviruses: identification of three genotypes. J Virol 2002; 76: 9124-9134.
392. Shackelton LA, Hoelzer K, Parrish CR, et al. Comparative analysis reveals frequent recombination in the parvoviruses. J Gen Virol 2007; 88: 3294-3301.
393. Shackelton LA, Holmes EC. Phylogenetic evidence for the rapid evolution of human B19 erythrovirus. J Virol 2006; 80: 3666-3669.
394. Shackelton LA, Parrish CR, Truyen U, et al. High rate of viral evolution associated with the emergence of carnivore parvovirus. Proc Natl Acad Sci U S A 2005; 102: 379-384.
395. Sharp CP, LeBreton M, Kantola K, et al. Widespread infection with homologues of human parvoviruses B19, PARV4, and human bocavirus of chimpanzees and gorillas in the wild. J Virol 2010; 84: 10289-10296.
396. Shi X, Fang G, Shi W, et al. Insertional mutagenesis at positions 520 and 584 of adeno-associated virus type 2 (AAV2) capsid gene and generation of AAV2 vectors with eliminated heparin-binding ability and introduced novel tropism. Hum Gene Ther 2006; 17: 353-361.
397. Shimomura S, Komatsu N, Frickhofen N, et al. First continuous propagation of B19 parvovirus in a cell line. Blood 1992; 79: 18-24.
398. Shimomura S, Wong S, Brown KE, et al. Early and late gene expression in UT-7 cells infected with B19 parvovirus. Virology 1993; 194: 149-156.
399. Siegl G. The parvoviruses. Virology Monographs, Vol. 15. New York: Springer Verlag; 1976.
400. Simmons R, Sharp C, Sims S, et al. High frequency, sustained T cell responses to PARV4 suggest viral persistence in vivo. J Infect Dis 2011; 203: 1378-1387.
401. Simpson AA, Chandrasekar V, Hebert B, et al. Host range and variability of calcium binding by surface loops in the capsids of canine and feline parvoviruses. J Mol Biol 2000; 300: 597-610.
402. Simpson AA, Chipman PR, Baker TS, et al. The structure of an insect parvovirus (Galleria mellonella densovirus) at 3.7 Å resolution. Structure 1998; 6: 1355-1367.
403. Simpson AA, Hebert B, Sullivan GM, et al. The structure of porcine parvovirus: comparison with related viruses. J Mol Biol 2002; 315: 1189-1198.
404. Slavov SN, Kashima S, Pinto AC, et al. Human parvovirus B19: general considerations and impact on patients with sickle-cell disease and thalassemia and on blood transfusions. FEMS Immunol Med Microbiol 2011; 62: 247-262.
405. Smith RH, Kotin RM. An adeno-associated virus (AAV) initiator protein, Rep78, catalyzes the cleavage and ligation of single-stranded AAV ori DNA. J Virol 2000; 74: 3122-3129.
406. Smith RH, Kotin RM. The Rep52 gene product of adeno-associated virus is a DNA helicase with 3'-to-5' polarity. J Virol 1998; 72: 4874-4881.
407. Snyder RO, Im DS, Ni T, et al. Features of the adeno-associated virus origin involved in substrate recognition by the viral Rep protein. J Virol 1993; 67: 6096-6104.
408. Snyder RO, Samulski RJ, Muzyczka N. In vitro resolution of covalently joined AAV chromosome ends. Cell 1990; 60: 105-113.
409. Song S, Lu Y, Choi YK, et al. DNA-dependent PK inhibits adeno-associated virus DNA integration. Proc Natl Acad Sci U S A 2004; 101: 2112-2116.
410. Sonntag F, Kother K, Schmidt K, et al. The assembly-activating protein promotes capsid assembly of different adeno-associated virus serotypes. J Virol 2011; 85: 12686-12697.
411. Spalholz BA, Tattersall P. Interaction of minute virus of mice with differentiated cells: strain-dependent target cell specificity is mediated by intracellular factors. J Virol 1983; 46: 937-943.
412. Srivastava A, Lusby EW, Berns KI. Nucleotide sequence and organization of the adeno-associated virus 2 genome. J Virol 1983; 45: 555-564.
413. Storgaard T, Oleksiewicz M, Bloom ME, et al. Two parvoviruses that cause different diseases in mink have different transcription patterns: transcription analysis of mink enteritis virus and Aleutian mink disease parvovirus in the same cell line. J Virol 1997; 71: 4990-4996.
414. Storz J, Young S, Carroll EJ, et al. Parvovirus infection of the bovine fetus: distribution of infection, antibody response, and age-related susceptibility. Am J Vet Res 1978; 39: 1099-1102.
415. Strassheim LS, Gruenberg A, Veijalainen P, et al. Two dominant neutralizing antigenic determinants of canine parvovirus are found on the threefold spike of the virus capsid. Virology 1994; 198: 175-184.
416. Straus SE, Sebring ED, Rose JA. Concatemers of alternating plus and minus strands are intermediates in adenovirus-associated virus DNA synthesis. Proc Natl Acad Sci U S A 1976; 73: 742-746.
417. Suikkanen S, Aaltonen T, Nevalainen M, et al. Exploitation of microtubule cytoskeleton and dynein during parvoviral traffic toward the nucleus. J Virol 2003; 77: 10270-10279.
418. Suikkanen S, Antila M, Jaatinen A, et al. Release of canine parvovirus from endocytic vesicles. Virology 2003; 316: 267-280.
419. Suikkanen S, Saajarvi K, Hirsimaki J, et al. Role of recycling endosomes and lysosomes in dynein-dependent entry of canine parvovirus. J Virol 2002; 76: 4401-4411.
420. Summerford C, Bartlett JS, Samulski RJ. aVb5 integrin: a co-receptor for adeno-associated virus type 2 infection. Nat Med 1999; 5: 78-82.
421. Summerford C, Samulski RJ. Membrane-associated heparan sulfate proteoglycan is a receptor for adeno-associated virus type 2 virions. J Virol 1998; 72: 1438-1445.
422. Takahashi T, Ozawa K, Takahashi K, et al. Susceptibility of human erythropoietic cells to B19 parvovirus in vitro increases with differentiation. Blood 1990; 75: 603-610.
423. Tattersall P. Replication of the parvovirus MVM I. Dependence of virus multiplication and plaque formation on cell growth. J Virol1972;10:586-590.
424. Tattersall P, Bergoin M, Bloom ME, et al. Parvoviridae. In: Fauquet CM, Mayo MA, Maniloff L, et al, eds. Virus Taxonomy. Amsterdam: Elsevier; 2005:353-369.
425. Tattersall P, Ward DC. Rolling hairpin model for replication of parvovirus and linear chromosomal DNA. Nature 1976; 263: 106-109.
426. Tezak Z, Nagaraju K, Plotz P, et al. Adeno-associated virus in normal and myositis human skeletal muscle. Neurology 2000; 55: 1913-1917.
427. Tobiasch E, Burguete T, Klein-Bauernschmitt P, et al. Discrimination between different types of human adeno-associated viruses in clinical samples by PCR. J Virol Methods 1998; 71: 17-25.
428. Tolfvenstam T, Broliden K. Parvovirus B19 infection. Semin Fetal Neonatal Med 2009; 14(4): 218-221.
429. Toolan HW. Degeneration of lens and overgrowth of Harderian glands in hamsters neonatally injected with parvovirus MVM-i. Proc Soc Exp Biol Med 1983; 172: 351-356.
430. Toolan HW. Experimental production of mongoloid hamsters. Science 1960; 131: 1446-1448.
431. Toolan HW. The parvoviruses. Prog Exp Tumor Res 1972; 16: 410-425.
432. Trempe JP, Carter BJ. Regulation of adeno-associated virus gene expression in 293 cells: control of mRNA abundance and translation. J Virol 1988; 62: 68-74.
433. Truyen U, Evermann JF, Vieler E, et al. Evolution of canine parvovirus involved loss and gain of feline host range. Virology 1996; 215: 186-189.
434. Truyen U, Gruenberg A, Chang SF, et al. Evolution of the feline-subgroup parvoviruses and the control of canine host range in vivo. J Virol 1995; 69: 4702-4710.
435. Tsao J, Chapman MS, Agbandje M, et al. The three-dimensional structure of canine parvovirus and its functional implications. Science 1991; 251: 1456-1464.
436. Tsao J, Chapman MS, Wu H, et al. Structure determination of monoclinic canine parvovirus. Acta Crystallogr B 1992; 48: 75-88.
437. Tsukada Y, Yokoyama K, Ishida A, et al. Erythroid crisis caused by parvovirus B19 transmitted via red blood cell transfusion. Intern Med 2011; 50: 2379-2382.
438. Tullis GE, Burger LR, Pintel DJ. The minor capsid protein VP1 of the autonomous parvovirus minute virus of mice is dispensible for encapsidation of progeny single stranded DNA but is required for infectivity. J Virol 1993; 67: 131-141.
439. Tullis GE, Burger LR, Pintel DJ. The trypsin-sensitive RVER domain in the capsid proteins of minute virus of mice is required for efficient cell binding and viral infection but not for proteolytic processing in vivo. Virology 1992; 191: 846-857.
440. Urabe M, Hasumi Y, Kume A, et al. Charged-to-alanine scanning mutagenesis of the N-terminal half of adeno-associated virus type 2 Rep78 protein. J Virol 1999; 73: 2682-2693.
441. Urcelay E, Ward P, Wiener SM, et al. Asymmetric replication in vitro from a human sequence element is dependent on adeno-associated virus Rep protein. J Virol 1995; 69: 2038-2046.
442. Vandenberghe LH, Wilson JM. AAV as an immunogen. Curr Gene Ther 2007; 7: 325-333.
443. Vihinen-Ranta M, Kakkola L, Kalela A, et al. Characterization of a nuclear localization signal of canine parvovirus capsid proteins. Eur J Biochem 1997; 250: 389-394.
444. Vihinen-Ranta M, Wang D, Weichert WS, et al. The VP1 N-terminal sequence of canine parvovirus affects nuclear transport of capsids and efficient cell infection. J Virol 2002; 76: 1884-1891.
445. Vihinen-Ranta M, Yuan W, Parrish CR. Cytoplasmic trafficking of the canine parvovirus capsid and its role in infection and nuclear transport. J Virol 2000; 74: 4853-4859.
446. Viuff B, Aasted B, Alexandersen S. Role of alveolar type II cells and of surfactant-associated protein C mRNA levels in the pathogenesis of respiratory distress in mink kits infected with Aleutian mink disease parvovirus. J Virol 1994; 68: 2720-2725.
447. Walters RW, Agbandje-McKenna M, Bowman VD, et al. Structure of adeno-associated virus serotype 5. J Virol 2004; 78: 3361-3371.
448. Wan CH, Soderlund-Venermo M, Pintel DJ, et al. Molecular characterization of three newly recognized rat parvoviruses. J Gen Virol 2002; 83: 2075-2083.
449. Wang D, Parrish CR. A heterogeneous nuclear ribonucleoprotein A/B-related protein binds to single-stranded DNA near the 5' end or within the genome of feline parvovirus and can modify virus replication. J Virol 1999; 73: 7761-7768.
450. Wang L, Calcedo R, Bell P, et al. Impact of pre-existing immunity on gene transfer to nonhuman primate liver with adeno-associated virus 8 vectors. Hum Gene Ther 2011; 22: 1389-1401.
451. Watson J, Thompson KN, Feldman SH. Successful rederivation of contaminated immunocompetent mice using neonatal transfer with iodine immersion. Comp Med 2005; 55: 465-469.
452. Weger S, Wistuba A, Grimm D, et al. Control of adeno-associated virus type 2 cap gene expression: relative influence of helper virus, terminal repeats, and Rep proteins. J Virol 1997; 71: 8437-8447.
453. Weichert WS, Parker JS, Wahid AT, et al. Assaying for structural variation in the parvovirus capsid and its role in infection. Virology 1998; 250: 106-117.
454. Weigel-Kelley KA, Yoder MC, Srivastava A. Alpha5beta1 integrin as a cellular coreceptor for human parvovirus B19: requirement of functional activation of beta1 integrin for viral entry. Blood 2003; 102: 3927-3933.
455. Weigel-Kelley KA, Yoder MC, Srivastava A. Recombinant human parvovirus B19 vectors: erythrocyte P antigen is necessary but not sufficient for successful transduction of human hematopoietic cells. J Virol 2001; 75: 4110-4116.
456. Weindler FW, Heilbronn R. A subset of herpes simplex virus replication genes provides helper functions for productive adeno-associated virus replication. J Virol 1991; 65: 2476-2483.
457. Weitzman MD, Kyostio SR, Kotin RM, et al. Adeno-associated virus (AAV) Rep proteins mediate complex formation between AAV DNA and its integration site in human DNA. Proc Natl Acad Sci U S A 1994; 91: 5808-5812.
458. Wilson GM, Jindal HK, Yeung DE, et al. Expression of minute virus of mice major nonstructural protein in insect cells: purification and identification of ATPase and helicase activities. Virology 1991; 185: 90-98.
459. Wistuba A, Kern A, Weger S, et al. Subcellular compartmentalization of adeno-associated virus type 2 assembly. J Virol 1997; 71: 1341-1352.
460. Wobus CE, Hugle-Dorr B, Girod A, et al. Monoclonal antibodies against the adeno-associated virus type 2 (AAV-2) capsid: epitope mapping and identification of capsid domains involved in AAV-2-cell interaction and neutralization of AAV-2 infection. J Virol 2000; 74: 9281-9293.
461. Wolter S, Richards R, Armentrout RW. Cell-cycle dependent replication of the DNA of minute virus of mice, a parvovirus. Biochem Biophys Acta 1980; 607: 420-431.
462. Wonderling RS, Kyostio SR, Owens RA. A maltose-binding protein/adeno-associated virus Rep68 fusion protein has DNA-RNA helicase and ATPase activities. J Virol 1995; 69: 3542-3548.
463. Woolf AD. Human parvovirus B19 and arthritis. Behring Inst Mitt 1990;(85):64-68.
464. Woolf AD, Campion GV, Chishick A, et al. Clinical manifestations of human parvovirus B19 in adults. Arch Intern Med 1989; 149: 1153-1156.
465. Wright C, Hinchliffe SA, Taylor C. Fetal pathology in intrauterine death due to parvovirus B19 infection. Br J Obstet Gynaecol 1996; 103: 133-136.
466. Wu CG, Mason B, Jong J, et al. Parvovirus B19 transmission by a high-purity factor VIII concentrate. Transfusion 2005; 45: 1003-1010.
467. Wu P, Xiao W, Conlon T, et al. Mutational analysis of the adeno-associated virus type 2 (AAV2) capsid gene and construction of AAV2 vectors with altered tropism. J Virol 2000; 74: 8635-8647.
468. Wu Z, Asokan A, Grieger JC, et al. Single amino acid changes can influence titer, heparin binding, and tissue tropism in different adeno-associated virus serotypes. J Virol 2006; 80: 11393-11397.
469. Xie Q, Bu W, Bhatia S, et al. The atomic structure of adeno-associated virus (AAV-2), a vector for human gene therapy. Proc Natl Acad Sci U S A 2002; 99: 10405-10410.
470. Yakobson B, Hrynko TA, Peak MJ, et al. Replication of adeno-associated virus in cells irradiated with UV light at 254 nm. J Virol 1989; 63: 1023-1030.
471. Yamamoto H, Sato H, Yagami K, et al. Microbiological contamination in genetically modified animals and proposals for a microbiological test standard for national universities in Japan. Exp Anim 2001; 50: 397-407.
472. Yan Z, Zak R, Zhang Y, et al. Distinct classes of proteasome-modulating agents cooperatively augment recombinant adeno-associated virus type 2 and type 5-mediated transduction from the apical surfaces of human airway epithelia. J Virol 2004; 78: 2863-2874.
473. Yang Q, Chen F, Ross J, et al. Inhibition of cellular and SV40 DNA replication by the adeno-associated virus Rep proteins. Virology 1995; 207: 246-250.
474. Ye C, Pintel DJ. The transcription strategy of bovine adeno-associated virus (B-AAV) combines features of both adeno-associated virus type 2 (AAV2) and type 5 (AAV5). Virology 2008; 370: 392-402.
475. Yoo BC, Lee DH, Park SM, et al. A novel parvovirus isolated from Manchurian chipmunks. Virology 1999; 253: 250-258.
476. Yoon-Robarts M, Blouin AG, Bleker S, et al. Residues within the B' motif are critical for DNA binding by the superfamily 3 helicase Rep40 of adeno-associated virus type 2. J Biol Chem 2004; 279: 50472-50481.
477. Yoshimoto K, Rosenfeld S, Frickhofen N, et al. A second neutralizing epitope of B19 parvovirus implicates the spike region in the immune response. J Virol 1991; 65: 7056-7060.
478. Young NS. B19 parvovirus. Baillieres Clin Haematol 1995; 8: 25-56.
479. Yuan W, Parrish CR. Canine parvovirus capsid assembly and differences in mammalian and insect cells. Virology 2001; 279: 546-557.
480. Zadori Z, Szelei J, Lacoste M-C, et al. A viral phospholipase A2 is required for parvovirus infectivity. Dev Cell 2001; 1: 291-302.
481. Zadori Z, Szelei J, Tijssen P. SAT: a late NS protein of porcine parvovirus. J Virol 2005; 79: 13129-13138.
482. Zaiss AK, Muruve DA. Immune responses to adeno-associated virus vectors. Curr Gene Ther 2005; 5: 323-331.
483. Zhao Q, Gersappe A, Pintel DJ. Efficient excision of the upstream large intron from P4-generated pre-mRNA of the parvovirus minute virus of mice requires at least one donor and the 3' splice site of the small downstream intron. J Virol 1995; 69: 6170-6179.
484. Zhou X, Muzyczka N. In vitro packaging of adeno-associated virus DNA. J Virol 1998; 72: 3241-3247.